Fukuda H, Shimizu T, Nakajima M, Mori H, Shirasawa T
PE Biosystems Japan Ltd., Tokyo.
Bioorg Med Chem Lett. 1999 Apr 5;9(7):953-6. doi: 10.1016/s0960-894x(99)00121-3.
Amyloid Abeta1-42 peptide (Abeta1-42) and its isomers with an isoaspartyl residue at position 7 or 23 [Abeta1-42(isoAsp7) and Abeta1-42(isoAsp23)] were synthesized in high purity by the Fmoc-solid phase technique, followed by HPLC on a silica-based reversed-phase column under the basic conditions. Importantly, Abeta1-42(isoAsp23) aggregated more strongly than native Abeta1-42 and showed significant neurotoxicity, while the aggregation ability and neurotoxicity of Abeta1-42(isoAsp7) was weak. This suggests that the isomerization of the aspartyl residues plays an important role in fibril formation in Alzheimer's disease.
采用Fmoc固相技术合成了高纯度的淀粉样β-蛋白1-42肽(Abeta1-42)及其在第7位或第23位带有异天冬氨酰残基的异构体[Abeta1-42(isoAsp7)和Abeta1-42(isoAsp23)],随后在碱性条件下于硅胶基反相柱上进行高效液相色谱分析。重要的是,Abeta1-42(isoAsp23)的聚集能力比天然Abeta1-42更强,并表现出显著的神经毒性,而Abeta1-42(isoAsp7)的聚集能力和神经毒性较弱。这表明天冬氨酰残基的异构化在阿尔茨海默病的原纤维形成中起重要作用。